Mexico /
In accordance with the time, the clinical trials of the vacancies against covid-19 are updated little by little and one of them is the Modern, the one indicating that is effective against illness at 90 per cent and a 95 per cent against the severe forms of the disease, according to the biotechnology study firm announced in the new published results, a few months ago in an anterior clinical trial.
Loose dates of a Phase 3 clinical trial in which more than 30 million people participate in the United States. The efficacy is lower than 94.1 per cent registered in a large clinical trial published in the New England Journal of Medicine in December.
Modernity in its communication and the reduction of efficacy is due to the appearance of new variants, pis the biotechnology company is working on two modified versions of its vehicle, specified for the variants, with results in ratios, but not yet revised by par.
“The new clinical data on our candidates and vacancies specific to the variants are ours and our confidence in anticipating the appearance of new variants”, applauded the mother of Modern, Stephane Bancel.
As of April 12, Modern Day has sent 132 million doses of its vaccine against covid to all over the world, including 117 million in the United States.
There will be a total of 100 million additional doses in the stadium for the Mayo finals, and another 100 million for the June finals.
The clinical trial of the company for adolescents aged 12 to 17 years with 3 million participants in the United States, and its follow-up to six months to 11 years with a total of 750 participants in the United States and China.
Bgpa